Health Condition 1: R05- Cough
Conditions
Interventions
Intervention1: WKF Syrup: WKF Syrup contains Adhatoda vasica, Zingiber officinale, Curcuma longa, Ocimum sanctum, Glycyrhiza glabra, Mentha arvensis.
Dosage and Treatment Duration: 2 TSF of syrup two
Sponsors
Welex laboratories Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject suffering from uncomplicated cough that does not require antibiotic treatment 2. The onset time should not be more than 3 days 3. Willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Cough caused by bronchial asthma, tuberculosis, bronchiectasis, and other diseases that have been clearly diagnosed as chronic obstructive pulmonary disease and/or severe respiratory tract infection. 2. Patient with known current lung cancer and fibrosis of lung 3. Patients with uncontrolled diabetes or hypertension; 4. Subjects with known current serious illness, e.g., multisystem failure, chronic liver disease, HIV, cancer, renal failure, serious cardiovascular disease. 5. Women during pregnancy or lactation or women who are preparing for pregnancy or lactation during the trial 6. Known allergy to any ingredient of study products 7. Any other conditions, which in the opinion of the investigator/s, makes the patient unsuitable for enrollment or could interfere with his/her participation and completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Comparative assessment of number of days required and number of subjects completely recovered from cough over a period of 14 days between the two groups 2.Comparative change in day and night frequencies of cough on a graded scale based on subject diary from baseline to end of therapy and between the two groups. Timepoint: Screening Visit (up to day 3), Baseline Visit (Day 0), Visit 1 Telephonic follow up (Day 4), Visit 2 (Day 7), Visit 3 Telephonic follow up (Day 10), Visit 4 (Day 14 or Complete resolution of Cough) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparative change in throat irritation on graded scale based on subject diary 2. Comparative change in sputum production on graded scale based on subject diary 3. Comparative assessment of requirement of rescue medications based on subject diary 4. Global assessment for overall change assessed by physician and subjects at the end of the study 5. Assessment of tolerability of study products by evaluating ADRs Timepoint: Screening Visit (up to day 3), Baseline Visit (Day 0), Visit 1 Telephonic follow up (Day 4), Visit 2 (Day 7), Visit 3 Telephonic follow up (Day 10), Visit 4 (Day 14 or Complete resolution of Cough) | — |
Countries
India
Contacts
Public ContactDr Sanjay Tamoli
Target Institute of Medical Education and Research Pvt. Ltd.
Outcome results
None listed